info@allievapharma.com


  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company

Product Details

Regorafenib Tablet BP 40mg

Regorafenib Tablet BP 40mg


Brand NameREGOLIEVA 40MG
CompositionRegorafenib Tablet BP 40mg
Manufacture ByAllieva Pharma Private Limited
FormTablet
PackingPack of 28 Tablets
Country Of OriginIndia

Description

Description

Regolieva contains Regorafenib, an oral targeted anticancer medicine. It is a multi-kinase inhibitor that blocks enzymes involved in tumor cell growth, angiogenesis (formation of new blood vessels), and cancer progression, thereby slowing or stopping the spread of cancer.

Uses

Regolieva (Regorafenib) is used in adults for the treatment of:

  1. Metastatic Colorectal Cancer (mCRC)
    – After failure of standard chemotherapy and biological therapies

  2. Gastrointestinal Stromal Tumor (GIST)
    – In patients previously treated with imatinib and sunitinib

  3. Hepatocellular Carcinoma (HCC)
    – In patients who were previously treated with sorafenib

Side Effects

Common side effects:

  • Fatigue, weakness

  • Hand–foot skin reaction (palmar-plantar erythrodysesthesia)

  • Diarrhea

  • Decreased appetite, weight loss

  • Mouth sores (stomatitis)

  • Hair thinning or hair loss

  • High blood pressure

Dosage
  • Recommended dose:
    160 mg once daily (4 tablets of 40 mg)

  • Taken for 21 consecutive days, followed by 7 days off

  • One treatment cycle = 28 days

  • Take tablets after a low-fat meal

  • Swallow whole with water (do not crush or chew)

 


24/7 Clients Support

Best Price

Quality Assurance
function changeImage(elem, src) { document.getElementById("mainImage").src = src; document.querySelectorAll(".thumbnail-container img").forEach(img => img.style.border = "2px solid transparent"); elem.style.border = "2px solid #007bff"; }
Allieva Pharma Event